Melanocortin receptor-specific peptides for treatment of sexual dysfunction
    2.
    发明授权
    Melanocortin receptor-specific peptides for treatment of sexual dysfunction 有权
    用于治疗性功能障碍的黑皮质素受体特异性肽

    公开(公告)号:US08487073B2

    公开(公告)日:2013-07-16

    申请号:US12952238

    申请日:2010-11-23

    IPC分类号: A61K38/00

    摘要: A melanocortin receptor agonist cyclic peptide of the formula where R, x and y are as defined in the specification, compositions and formulations including the peptide of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including sexual dysfunction such as male erectile dysfunction and female sexual dysfunction.

    摘要翻译: 下式的黑皮质素受体激动剂环肽其中R,x和y如说明书中所定义,包括上述式的肽的组合物和制剂,以及预防,改善或治疗黑皮质素受体介导的疾病,适应症,条件 和综合征,包括性功能障碍如男性勃起功能障碍和女性性功能障碍。

    Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
    3.
    发明申请
    Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669 审中-公开
    黑皮质素受体特异性肽用于治疗肥胖/ 669

    公开(公告)号:US20090305960A1

    公开(公告)日:2009-12-10

    申请号:US12480420

    申请日:2009-06-08

    IPC分类号: A61K38/12 C07K7/64 A61P3/00

    CPC分类号: C07K7/54 A61K38/00 C07K7/06

    摘要: Melanocortin receptor-specific cyclic peptides of the formula where R1, R2, R3, R4, x and y are as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including obesity, diabetes, modulation of feeding behavior and related metabolic syndrome.

    摘要翻译: 其中R1,R2,R3,R4,x和y如说明书中所定义的组合物和制剂,包括上述式的肽的黑皮质素受体特异性环肽,以及预防,改善或治疗黑皮质素受体 - 介导的疾病,适应症,病症和综合症,包括肥胖症,糖尿病,调节摄食行为和相关的代谢综合征。

    Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction
    4.
    发明申请
    Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction 有权
    用于治疗性功能障碍的黑皮质素受体特异性肽

    公开(公告)号:US20110065652A1

    公开(公告)日:2011-03-17

    申请号:US12952238

    申请日:2010-11-23

    IPC分类号: A61K38/12 C07K7/00 A61P15/00

    摘要: A melanocortin receptor agonist cyclic peptide of the formula where R, x and y are as defined in the specification, compositions and formulations including the peptide of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including sexual dysfunction such as male erectile dysfunction and female sexual dysfunction.

    摘要翻译: 下式的黑皮质素受体激动剂环肽其中R,x和y如说明书中所定义,包括上述式的肽的组合物和制剂,以及预防,改善或治疗黑皮质素受体介导的疾病,适应症,条件 和综合征,包括性功能障碍如男性勃起功能障碍和女性性功能障碍。

    Linear and cyclic melanocortin receptor-specific peptidomimetics
    6.
    发明授权
    Linear and cyclic melanocortin receptor-specific peptidomimetics 有权
    线性和环状黑皮质素受体特异性肽模拟物

    公开(公告)号:US08114844B2

    公开(公告)日:2012-02-14

    申请号:US12244880

    申请日:2008-10-03

    摘要: Linear and cyclic peptidomimetics which bind to one or more melanocortin receptors are provided, which peptidomimetics include at least one ring-constrained amino acid surrogate of formula I: where R1, R2, R3, R4, R5, R6, R7, R8, and y are as defined in the specification, together with methods for synthesizing ring-constrained amino acid surrogates of formula I and peptidomimetics incorporating the same, and methods of use of peptidomimetics in the treatment of various diseases, syndromes and conditions.

    摘要翻译: 提供了结合一种或多种黑皮质素受体的线性和环肽模拟物,其中肽模拟物包括至少一个式I的环受限氨基酸替代物:其中R1,R2,R3,R4,R5,R6,R7,R8和y 以及用于合成式I的环受限制的氨基酸替代物的方法和包含其的肽模拟物的方法,以及使用肽模拟物治疗各种疾病,综合征和病症的方法。

    Cyclic natriuretic peptide constructs
    8.
    发明授权
    Cyclic natriuretic peptide constructs 有权
    循环利钠肽构建体

    公开(公告)号:US07622440B2

    公开(公告)日:2009-11-24

    申请号:US11694260

    申请日:2007-03-30

    IPC分类号: A61K38/12 A61K38/10

    CPC分类号: C07K14/58

    摘要: Cyclic constructs with an N-terminus and a C-terminus which bind to a natriuretic peptide receptor and include a plurality of amino acid residues, at least one amino acid surrogate of formula I: where R, R′, Q, Y, W, Z, J, x and n are as defined in the specification, and optionally at least one prosthetic group, pharmaceutical compositions including such cyclic constructs, and methods of treating congestive heart failure or other conditions, syndromes or diseases for which induction of anti-hypertensive, cardiovascular, renal or endocrine effects are desired.

    摘要翻译: 具有结合利尿钠肽受体并包含多个氨基酸残基的N末端和C末端的至少一个式I的氨基酸替代物的环状构建体:其中R,R',Q,Y,W, Z,J,x和n如说明书中所定义,以及任选的至少一个假体基团,包括这种环状构建体的药物组合物,以及治疗充血性心力衰竭或其它病症的方法,综合征或疾病,其诱导抗高血压 ,心血管,肾脏或内分泌效应。

    Linear natriuretic peptide constructs
    9.
    发明授权
    Linear natriuretic peptide constructs 有权
    线性利钠肽构建体

    公开(公告)号:US07795221B2

    公开(公告)日:2010-09-14

    申请号:US11694358

    申请日:2007-03-30

    IPC分类号: A61K38/10

    摘要: Linear constructs with an N-terminus and a C-terminus which bind to a natriuretic peptide receptor and include a plurality of amino acid residues and at least one amino acid surrogate of formula I: where R, R′, Q, Y, W, Z, J, x and n are as defined in the specification, and optionally at least one prosthetic group covalently bound to a reactive group of at least one of the amino acid residues or surrogates, pharmaceutical compositions including such linear constructs, and methods of treating congestive heart failure or other conditions, syndromes or diseases for which induction of anti-hypertensive, cardiovascular, renal or endocrine effects are desired.

    摘要翻译: 具有与利尿钠肽受体结合的N末端和C末端并且包括多个氨基酸残基和至少一个式I的氨基酸替代物的线性构建体:其中R,R',Q,Y,W, Z,J,x和n如说明书中所定义,以及任选地至少一个与至少一个氨基酸残基或替代物的反应性基团共价结合的假基团,包括这种线型构建体的药物组合物,以及治疗方法 充血性心力衰竭或其它需要诱导抗高血压,心血管,肾或内分泌作用的综合征或疾病。

    Cyclic Natriuretic Peptide Constructs
    10.
    发明申请
    Cyclic Natriuretic Peptide Constructs 有权
    循环利钠肽构建体

    公开(公告)号:US20100075895A1

    公开(公告)日:2010-03-25

    申请号:US12622055

    申请日:2009-11-19

    IPC分类号: A61K38/12 C07K7/50

    CPC分类号: C07K14/58

    摘要: Cyclic constructs with an N-terminus and a C-terminus which bind to a natriuretic peptide receptor and include a plurality of amino acid residues, at least one amino acid surrogate of formula I: where R, R′, Q, Y, W, Z, J, x and n are as defined in the specification, and optionally at least one prosthetic group, pharmaceutical compositions including such cyclic constructs, and methods of treating congestive heart failure or other conditions, syndromes or diseases for which induction of anti-hypertensive, cardiovascular, renal or endocrine effects are desired.

    摘要翻译: 具有结合利尿钠肽受体并包含多个氨基酸残基的N末端和C末端的至少一个式I的氨基酸替代物的环状构建体:其中R,R',Q,Y,W, Z,J,x和n如说明书中所定义,以及任选的至少一个假体基团,包括这种环状构建体的药物组合物,以及治疗充血性心力衰竭或其它病症的方法,综合征或疾病,其诱导抗高血压 ,心血管,肾脏或内分泌效应。